LAG-3 checkpoint inhibitor/IL-15/IL-15 receptor alpha (Xencor)

N/A

Report date: 2025/03/20 14:49:26

Base Information

Drug NameLAG-3 checkpoint inhibitor/IL-15/IL-15 receptor alpha (Xencor)
Drug Alias Namebispecific IL-15/IL-15 receptor alpha sushi complex/anti-LAG-3 Fab fusion (Xencor)LAG3 x IL15 bispecific Fc fusion
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-15 receptors replacement
TargetsInterleukin-15 receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXencor Inc
China Registration ClassN/A

Develop Information

Active CompaniesXencor Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A